Skip to Content

M LH2 (Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg)

Pill with imprint M LH2 is Yellow, Round and has been identified as Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg. It is supplied by Mylan Pharmaceuticals Inc..

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LH2

Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg M LH2
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg M LH2 Front
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg M LH2 Back
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg M LH2

Hydrochlorothiazide and Lisinopril

Imprint
M LH2
Strength
12.5 mg / 20 mg
Color
Yellow
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Ace inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, calcium phosphate dihydrate dibasic, D&C Yellow No. 10, magnesium stearate, mannitol, microcrystalline cellulose, corn starch, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2012 Mylan Pharmaceuticals Inc.
51079-0698 UDL Laboratories Inc.
54868-4637 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.